Coronavirus: Scientists concerned by way data from Chinese drug firm Sinovac’s vaccine trials is coming out

• The firm’s Brazilian partner the Butantan Institute has promised to disclose more information after it claimed the drug had a 78 per cent efficacy rate
• But researchers question the figure and ask why the Chinese pharmaceutical company has not commented publicly on the trial results